Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on X:
“This is how we build the ‘World Bank of NK Cells‘ and make Immunotherapy 2.0 accessible to all of humanity. Our M-ceNK Phase 2 clinical trials ongoing with process development from over 60 healthy volunteers and patients with cancer completed to date.
The future of growing natural killer (NK) cells to fight cancer and protect our immune systems is being assembled right now (NANT Leonardo), the first AI machine driven, cell therapy robotic manufacturing system landing soon!”
Other articles about Immunotherapy on OncoDaily.